Public Company News

Weibo Announces Results of 2022 Annual General Meeting

BEIJING, June 6, 2022 /PRNewswire/ -- Weibo Corporation ("Weibo" or the "Company") (NASDAQ: WB and HKEX: 9898), a leading social media inChina, today announced that the following proposed resolutions submitted for shareholder approval have been adopted at its 2022 annual general meeting of shareh...

2022-06-06 17:00 3708

"Captain Tsubasa: Dream Team" 5th Anniversary Kicks Off & New Players Wearing the JUVENTUS Official Kit Debut

TOKYO, June 6, 2022 /PRNewswire/ -- KLab Inc., a leader in online mobile games, announced that its head-to-head football simulation gameCaptain Tsubasa: Dream Teamkicked off its special 5th Anniversary with the JUVENTUS OFFICIAL CAMPAIGN: Gifts for All and more in-game campaigns onFriday, June 3....

2022-06-06 15:15 3099

Vection Technologies Announces Metaverse Integration for Webex Meetings at Cisco LIVE 2022

News Summary: * Vection Technologies is bringing its virtual worlds creation capabilities to Webex Meetings * Webex-first solution will be previewed at Cisco Live! in Las Vegas June 12-16 LAS VEGAS, June 6, 2022 /PRNewswire/ -- Vection Technologies is collaborating with Webex by Cisco to mak...

2022-06-06 14:18 3207

Gaotu Techedu Announces First Quarter of 2022 Unaudited Financial Results

BEIJING, June 6, 2022 /PRNewswire/ -- Gaotu Techedu Inc. (NYSE: GOTU) ("Gaotu" or the "Company"), a technology-driven education company and online large-class tutoring service provider inChina, today announced its unaudited financial results for the first quarter endedMarch 31, 2022. First Quart...

2022-06-06 14:00 5275

Market update: Strong tanker market due to sanctions and high demand for oil - Concordia Maritime

GÖTEBORG, Sweden, June 6, 2022 /PRNewswire/ -- The product tanker market has strengthened significantly during April and May, with market rates at much higher levels than for both Q1 2022 and the full year 2021. At the end of May, average spot market earnings for an MR vessel (clean) was about$36...

2022-06-06 13:39 3103

CStone and Pfizer announce NMPA approval of sugemalimab in patients with unresectable stage III non-small cell lung cancer

* The National Medical Products Administration approved sugemalimab for the treatment of patients with unresectable stage III non-small cell lung cancer whose disease has not progressed following concurrent or sequential platinum-based chemoradiotherapy * Sugemalimab became the first anti-PD-...

2022-06-06 13:15 4547

CStone and Pfizer announce NMPA approval of sugemalimab in patients with unresectable stage III non-small cell lung cancer

* The National Medical Products Administration approved sugemalimab for the treatment of patients with unresectable stage III non-small cell lung cancer whose disease has not progressed following concurrent or sequential platinum-based chemoradiotherapy * Sugemalimab became the first anti-PD-...

2022-06-06 12:23 3392

iQIYI Showcases Technology-Enabled Green Production Techniques on World Environment Day

BEIJING, June 6, 2022 /PRNewswire/ -- On Jun. 5, iQIYI, an innovative market-leading online entertainment service inChina, shared its commitment to a sustainable future on World Environment Day, a day where businesses, communities, and governments around the world come together to raise awareness...

2022-06-06 12:20 6846

Poster Highlighting Phase II Clinical Study of KN026 for HER2-expressing Advanced GC/GEJ Presented at 2022 ASCO

SUZHOU, China, June 6, 2022 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. (stock code: 1093.HK) jointly announced that data from a phase II clinical study of KN026 (HER2 bispecific antibody) monotherapy in patients with previously treated, advance...

2022-06-06 10:49 3538

Research Updates on KN046 Presented at 2022 ASCO

SUZHOU, China, June 6, 2022 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that research updates from four clinical studies of KN046 (PD-L1/CTLA-4 bispecific antibody) presented as a poster or published online at the 2022 American Society of Clinical Oncology Annual Meeting (20...

2022-06-06 09:47 3704

SocietyOne launches transaction & savings accounts powered by Westpac

SYDNEY, June 6, 2022 /PRNewswire/ -- In its first major corporate milestone following its acquisition by MONEYME Ltd (ASX:MME), digital finance platform SocietyOne has launched transaction and savings accounts powered by Westpac's Banking-as-a-Service (BaaS).

2022-06-06 09:25 4215

Akeso releases promising data of Ivonescimab (PD-1/VEGF BsAbs, AK112) combined with chemotherapy in advanced NSCLC at ASCO 2022

HONG KONG, June 5, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, released clinical details in poster discussion featuring a phase II ...

2022-06-06 09:00 2569

Akeso announces oral presentation featuring promising clinical data of Cadonilimab (PD-1/CTLA-4 BsAbs, AK104) for the first-line treatment of R/M cervical cancer at ASCO 2022

HONG KONG, June 5, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, released updated results of Cadonilimab (PD-1/CTLA-4 Bispecific, AK...

2022-06-06 09:00 2411

Akeso releases promising data of Ivonescimab (PD-1/VEGF BsAbs, AK112) for advanced NSCLC at ASCO 2022

HONG KONG, June 5, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, released clinical details in poster presentation featuring phase Ib...

2022-06-06 09:00 2639

WuXi Biologics Launches First Commercial Drug Product Facility for Pre-Filled Syringes

* WuXi Biologics offers global partners high-efficiency and high-quality manufacturing services for clinical trial and commercial supply by increasing pre-filled syringes (PFS) capacity to 17 million units per year. * WuXi Biologics has established a global manufacturing network with 9 drug p...

2022-06-06 08:30 5069

Innovent Presents Clinical Data of IBI110 (Anti-LAG-3 Monoclonal Antibody) at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

SAN FRANCISCO and SUZHOU, China, June 6, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and ...

2022-06-06 08:08 4133

Innovent Presents Clinical Data of Phase I Study for IBI351 (KRAS G12C Inhibitor) as Monotherapy for Solid Tumors at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

SAN FRANCISCO and SUZHOU, China, June 6, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and ...

2022-06-06 08:00 4188

Innovent and IASO Bio Jointly Announce the NMPA Acceptance of the New Drug Application for Equecabtagene Autoleucel for the Treatment of Relapsed and/or Refractory Multiple Myeloma

SAN FRANCISCO and SUZHOU, China, June 6, 2022  /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...

2022-06-06 08:00 4090

Pepper Money's SOLANA Improves Business Volumes by 70% with the Appian Low-Code Platform

SYDNEY, June 6, 2022 /PRNewswire/ -- Appian (NASDAQ: APPN) announced today that Pepper Money, a leading consumer finance company inAustralia is using the  Appian Low-Code Platform to support its Asset Finance Loan Origination solution, SOLANA, which has allowed the company to grow its business vol...

2022-06-06 07:00 4501

Angel Yeast Increases New Energy Procurement in Green Push to Curb Carbon Emission

YICHANG, China, June 5, 2022 /PRNewswire/ -- Angel Yeast (en.angelyeast.com) (SH600298), a listed global yeast and yeast extract manufacturer, is glad to announce that the Company has been granted the green electricity certificate issued and certified by China Hubei Power Exchange Center and Chin...

2022-06-05 21:00 5777